Bedrood describes improved visualization of the ciliary body, efficient setup, and favorable postoperative outcomes.

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...

Innovations in selective laser trabeculoplasty and laser cyclophotocoagulation focus on procedural efficiency, patient ...

Ophthalmologists from across the United States and around the globe gathered in Orlando, Florida over the October 17 through ...

Philip J. Ferrone, MD, is partner with Vitreoretinal Consultants of New York and professor of ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.